Evolva Holding SA
EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was formerly known as Evolva Holding SA… Read more
Market Cap & Net Worth: Evolva Holding SA (ELVAF)
Evolva Holding SA (PINK:ELVAF) has a market capitalization of $6.49 Million ($6.49 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #31407 globally and #10331 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Evolva Holding SA's stock price $0.90 by its total outstanding shares 7211550 (7.21 Million).
Evolva Holding SA Market Cap History: 2015 to 2025
Evolva Holding SA's market capitalization history from 2015 to 2025. Data shows change from $1.75 Billion to $6.49 Million (-44.96% CAGR).
Evolva Holding SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Evolva Holding SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
Evolva Holding SA's market cap is 0.65 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.75 Billion | $9.40 Million | -$31.89 Million | 186.45x | N/A |
| 2016 | $991.16 Million | $8.75 Million | -$35.97 Million | 113.30x | N/A |
| 2017 | $459.74 Million | $6.85 Million | -$38.98 Million | 67.14x | N/A |
| 2018 | $378.61 Million | $8.93 Million | -$29.21 Million | 42.38x | N/A |
| 2019 | $459.74 Million | $11.60 Million | -$21.64 Million | 39.65x | N/A |
| 2020 | $396.64 Million | $7.54 Million | -$29.87 Million | 52.60x | N/A |
| 2021 | $251.68 Million | $9.88 Million | -$41.27 Million | 25.48x | N/A |
| 2022 | $1.08 Million | $15.54 Million | -$43.37 Million | 0.07x | N/A |
| 2023 | $6.17 Million | $9.44 Million | -$105.23 Million | 0.65x | N/A |
Competitor Companies of ELVAF by Market Capitalization
Companies near Evolva Holding SA in the global market cap rankings as of March 19, 2026.
Key companies related to Evolva Holding SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Evolva Holding SA Historical Marketcap From 2015 to 2025
Between 2015 and today, Evolva Holding SA's market cap moved from $1.75 Billion to $ 6.49 Million, with a yearly change of -44.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.49 Million | 0.00% |
| 2024 | $6.49 Million | +5.14% |
| 2023 | $6.17 Million | +470.67% |
| 2022 | $1.08 Million | -99.57% |
| 2021 | $251.68 Million | -36.55% |
| 2020 | $396.64 Million | -13.73% |
| 2019 | $459.74 Million | +21.43% |
| 2018 | $378.61 Million | -17.65% |
| 2017 | $459.74 Million | -53.62% |
| 2016 | $991.16 Million | -43.45% |
| 2015 | $1.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Evolva Holding SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.49 Million USD |
| MoneyControl | $6.49 Million USD |
| MarketWatch | $6.49 Million USD |
| marketcap.company | $6.49 Million USD |
| Reuters | $6.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.